Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311902 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yuya Mizukami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Kindai University Faculty of Medicine, Department of Physiology and Regenerative Medicine, Osakasayama, Osaka, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Adenine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Salt Science Research Foundation.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is a significant global health issue and often involves CKD-mineral and bone disorder (MBD) and sarcopenia. Plasminogen activator inhibitor-1 (PAI-1) is an inhibitor of fibrinolysis. PAI-1 has been implicated in the pathogenesis of osteoporosis and muscle wasting induced by inflammatory conditions. However, the roles of PAI-1 in CKD-MBD and sarcopenia remain unknown. Therefore, the present study investigated the roles of PAI-1 in bone loss and muscle wasting induced by adenine in PAI-1-deficient mice. CKD was induced in PAI-1 +/+ and PAI-1 -/- mice by administration of adenine for ten weeks. Muscle wasting was assessed by grip strength test, quantitative computed tomography (CT) analysis and muscle weight measurement. Osteoporosis was assessed by micro-CT analysis of femoral microstructural parameters. PAI-1 deficiency did not affect adenine-induced decreases in body weight and food intake or renal dysfunction in male or female mice. PAI-1 deficiency also did not affect adenine-induced decreases in grip strength, muscle mass in the lower limbs, or the tissue weights of the gastrocnemius, soleus, and tibialis anterior muscles in male or female mice. PAI-1 deficiency aggravated trabecular bone loss in CKD-induced male mice, but significantly increased trabecular bone in CKD-induced female mice. On the other hand, PAI-1 deficiency did not affect cortical bone loss in CKD-induced mice. In conclusion, PAI-1 is not critical for the pathophysiology of CKD-MBD or CKD-induced sarcopenia in mice. However, PAI-1 may be partly related to bone metabolism in trabecular bone in the CKD state with sex differences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kindai University Faculty of Medicine, Department of Physiology and Regenerative Medicine, Osakasayama, Osaka, Japan.
ORCID-Profile: Yuya Mizukami, Hiroshi Kaji
Förderung
- Japan Society for the Promotion of Science
- Salt Science Research Foundation
Zitieren
APA
Mizukami, Y., Kawao, N., Ohira, T., Okada, K., Yamao, H., Matsuo, O., & Kaji, H. (2024). Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice. PLOS ONE. https://doi.org/10.1371/journal.pone.0311902
Vancouver
Mizukami Y, Kawao N, Ohira T, Okada K, Yamao H, Matsuo O, et al. Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice. PLOS ONE. 2024. doi:10.1371/journal.pone.0311902
BibTeX
@article{Mizukami2024,
author = {Mizukami, Yuya and Kawao, Naoyuki and Ohira, Takashi and Okada, Kiyotaka and Yamao, Hisatoshi and Matsuo, Osamu and Kaji, Hiroshi},
title = {Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311902}
}
EUVIMED